Market
Primary Impact of Vapeador Ban in Mexico by End of 2025?
1
Resolution / Starting Odds
Decrease in usage • 25%
Increase in illegal markets • 25%
No significant change • 25%
Other • 25%
Reports and studies from health organizations, government reports, and media analysis
Story
Mexico's Cámara de Diputados Approves Ban on Vapeadores and Fentanilo with 410 Votes, 24 Against, No Abstentions on December 3, 2024
Dec 3, 2024, 08:59 PM
On December 3, 2024, the Cámara de Diputados in Mexico approved a constitutional reform to prohibit the production, distribution, and commercialization of vapeadores (vape devices) and cigarrillos electrónicos (electronic cigarettes). The reform received overwhelming support, passing with 410 votes in favor, 24 against, and no abstentions. This legislative action aims to protect public health and combat the illicit use of substances, including fentanilo (fentanyl). The reform will now proceed to the presidential sanction after being approved in its final debate. During the discussions, several legislators expressed concerns that the prohibition could lead to an increase in illegal markets and did not effectively address the consumption issue. Notably, some opposition members criticized the ban, arguing for regulation instead of prohibition, highlighting that such measures may not yield the desired results in curbing usage.
View original story
Similar markets
Decrease in market share for tobacco-flavored products • 25%
Increase in market share for tobacco-flavored products • 25%
Decrease in market share for non-tobacco flavored products • 25%
Increase in market share for non-tobacco flavored products • 25%
Moderate improvement • 25%
Significant improvement • 25%
Worsening • 25%
No change • 25%
Increase in e-cigarette waste • 25%
Moderate reduction in e-cigarette waste • 25%
Significant reduction in e-cigarette waste • 25%
No significant change in e-cigarette waste • 25%
Stricter regulations • 33%
No change • 34%
Looser regulations • 33%
Proposal blocked by administration • 25%
Proposal finalized and implemented • 25%
Proposal finalized but not implemented • 25%
Proposal withdrawn by FDA • 25%
Other sentiment shift • 25%
More favorable • 25%
Less favorable • 25%
Unchanged • 25%
Significant reduction in smoking rates • 25%
Moderate reduction in smoking rates • 25%
No change in smoking rates • 25%
Increase in smoking rates • 25%
No major reaction • 25%
Significant withdrawal from Belgian market • 25%
Legal challenges against the ban • 25%
Introduction of non-disposable alternatives • 25%
Data Unavailable • 25%
No Change • 25%
Increase • 25%
Decrease • 25%